Managers
Actic International, a holding company owned by the IK 2007 Fund, is to sell 6,647,078 shares in Actic Group AB (Actic) to nine high quality Swedish investors, including Athanase Industrial Partner (Athanase).
As a result, Athanase, a cornerstone investor in the listing of Actic, will increase its holding in Actic from approximately 7.9 per cent to 15.4 per cent of the total number of shares outstanding. The IK 2007 Fund, meanwhile, advised by IK Investment Partners, will no longer own any shares in Actic.
SEB acted as Sole Bookrunner in the transaction.
Funds managed by Inflexion Private Equity have acquired Atcore Group (Atcore), a leading travel technology company which provides specialist software platforms for the global leisure travel sector.
With clients such as TUI, Thomas Cook and Mark Warner, Atcore comprises of two principal platforms, Atcom and Tigerbay. Atcom designs, builds and maintains reservation software for leading global tour operators. Its proprietary reservation system is highly complex, and supports sophisticated business models which allow clients to manage large volumes of search requests, optimise customer experience and enhance profitability. Tigerbay serves specialist travel companies. It operates a dynamic, flexible, end to end platform
Italmatch Chemicals Group (Italmatch) is to acquire Detrex for USD27 a share in cash following the agreement of a merger deal between the two companies.
Under the terms of the Merger Agreement dated 10 November, 2017, each share of Detrex common stock outstanding immediately prior to the merger will be converted into and exchanged for the right to receive USD27.00 in cash. The merger consideration represents an 8 per cent premium over the closing bid price of Detrex’s common stock as quoted on the website of OTC Markets Group on 9 November, 2017, and a 9 per cent premium over
OMERS Private Equity, the private equity investment arm of the OMERS pension plan has entered into an agreement with Ardian to acquire a majority stake in Trescal, a specialist in calibration services.
The proposed transaction, which values the Company at approximately EUR670 million, is fully supported by Trescal’s management team headed by its CEO Olivier Delrieu. The proposed transaction will see the senior management make an equity reinvestment into Trescal alongside OMERS Private Equity.
The proposed transaction remains subject to several conditions including customary approvals by the antitrust authorities and signing of a definitive agreement. Headquartered in Paris, France Trescal operates across more than 110
Roynat Equity Partners has sold internet access business NetSet to Xplornet Communications (Xplornet). Based in Brandon, Manitoba, NetSet provides next generation broadband services throughout the province of Manitoba.
Xplornet will maintain the NetSet Communications trade name and will retain virtually all of NetSet’s employees and business operations in both Brandon and Winnipeg.
Roynat Equity Partners has been a shareholder of NetSet since 2014, providing value-added capital to help the company rapidly grow its geographic footprint and subscriber base throughout the province.
Rosewood Private Investments (RPI) has acquired a majority equity in ProTec Laboratory (ProTec), a provider of contract manufacturing services to consumer brands in the dietary supplements, sports nutrition, functional foods, and pet care products industries.
The investment in ProTec represents the third within RPI’s holding company, International Nutrition & Wellness Holdings (INW Holdings), and the second this year under INW Holdings CEO Paul Richardson. In July, INW acquired Irving, Texas-based contract manufacturer, Healthy Natural, Inc. (Healthy Natural), from Rice-Bran Technologies. INW also holds an ownership stake in United I International Laboratories (“United I”), a Carrollton, Texas-based manufacturer of dietary supplements, sports nutrition and personal care products. Together the companies offer an array of manufacturing capabilities and serve
The State Street Global Exchange SM Private Equity Index (GXPEI) ended the second quarter of 2017 with continued strong performance of 3.96 per cent, in line with the 3.95 per cent return posted in the first quarter.
The GXPEI is based on directly-sourced limited partnership data and represents more than USD2.5 trillion in private equity investments, with more than 2,800 unique private equity partnerships, as of 30 June 2017.
“European funds had a very strong quarter, partly driven by a weaker US dollar,” says Will Kinlaw, senior managing director and global head of State Street Associates®, a division of
Vestar Capital Partners (Vestar) is to acquire to acquire Nonni’s Food Group (Nonni’s), a manufacturer of artisanal biscuits and other baked snacks from Wind Point Partners.
Terms of the transaction, which is expected to close in the fourth quarter of 2017, have not been disclosed.
Nonni’s products are marketed under the Nonni’s, THINaddictives, and La Dolce Vita brand names, and sold through a diverse distribution platform that includes major customers in club, grocery, mass market, foodservice, and online retailing.
“Our partnership with Wind Point has been extraordinarily successful and we thank them for their support and contributions to
Western NIS Enterprise Fund (WNISEF) has launched U.Ventures, a new fund focusing on investing in early stage technology startups from Ukraine and Moldova.
U.Ventures will invest in early stage companies, from Seed to Series A, with investments ranging from USD100,000 to USD500,000. U.Ventures will back start-ups from Ukraine and Moldova that typically have a product with first traction, targeting large addressable markets, with a technology edge, driven by motivated teams with proven track record, and reputable co-investors.
To date U.Ventures has invested just over USD2.3 million in six companies which are emerging leaders in their segments, quickly expanding into
Apellis Pharmaceuticals, a portfolio company of early-stage venture capital fund Epidarex Capital, has completed its initial public offering (IPO).
Apellis began trading on the NASDAQ Global Select Market under the ticker symbol “APLS” on Thursday, 9 November. Having raised gross proceeds of circa USD150 million from the offering.
Epidarex and its predecessor fund, MASA Life Science Ventures, were among the company’s earliest backers, funding the development of the company’s core technology shortly after its spin-out from the University of Pennsylvania. Sinclair Dunlop, Co-founder and Managing Partner of Epidarex, having served on the Board of Directors since the initial investment,
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
